Gaviscon, mint suspension, 150ml

Product description

Gaviscon®, oral suspension [peppermint]. When taken orally, Gaviscon ® forms a protective barrier on the surface of the stomach contents, preventing acid from flowing from the stomach to the esophagus for up to four hours. A reduction in irritation is felt 3-4 minutes after ingestion. The mechanism of action of the active substances of Gaviscon® is physical and does not depend on absorption into the systemic circulation.

Composition

10 ml of suspension contains: active ingredients: sodium alginate 500 mg, sodium bicarbonate 267 mg, calcium carbonate 160 mg, excipients: carbomer 65 mg, methyl parahydroxybenzoate 40 mg, propyl parahydroxybenzoate 6 mg, sodium saccharinate 10 mg, peppermint oil 1 mg, sodium hydroxide 26.667 mg, purified water up to 10 ml

Pharmacological action

When taken orally, Gaviscon reacts quickly with acidic stomach contents.

In this case, an alginate gel is formed, which prevents the occurrence of gastroesophageal reflux.

During regurgitation, the gel is more likely than the contents of the stomach to enter the esophagus, where it reduces irritation of the mucous membrane.

Indications

Symptomatic treatment of dyspepsia associated with increased acidity of gastric juice and gastroesophageal reflux (heartburn, acid belching) ; feeling of heaviness in the stomach after eating, including during pregnancy.

Use during pregnancy and lactation

Gaviscon can be used during pregnancy and lactation.

Contraindications

Hypersensitivity to any of the components of the drug, children (up to 6 years).

Side effects

Possible allergic reactions.

How to take, course of use and dosage

Inside, after meals and before going to bed.

Adults and children over 12 years of age — 10-20 ml each. The maximum daily dose is 80 ml.

Children 6-12 years — 5-10 ml. The maximum daily dose is 40 ml.

For older patients, no dose adjustment is required.

Overdose

Symptoms: bloating may occur.

Treatment: symptomatic.

Special instructions

If there is no improvement in symptoms within 7 days, you should consult your doctor.

In 10 ml of the suspension, the sodium content is 141 mg (6.2 mmol).

This should be taken into account if a diet with a limited salt content is necessary, for example in some cases of congestive heart failure and kidney function disorders.

Form of production

Suspension for oral use.

Storage conditions

Store at a temperature of 15 °C to 25 °C. Keep out of reach of children.

Shelf life

3 years

Active ingredient

Sodium Alginate, Sodium Bicarbonate, Calcium Carbonate

Dosage form

suspension for oral use

Description

For pregnant women, Children over 12 years of age, Adults, Nursing mothers

Indications

Gastric and Duodenal ulcers, Gastritis, Reflux Esophagitis, Heartburn